默克-JPM-202401.pdf

1、MeRck J.P.MorganHealthcare ConferenceJanuary 2024Disclaimer2Cautionary Note Regarding Forward-Looking Statements and financial indicatorsThis communication may include“forward-looking statements.”Statements that include words such as“anticipate,”“expect,”“should,”“would,”“intend,”“plan,”“project,”“s

2、eek,”“believe,”“will,”and other words of similar meaning in connection with future events or future operating or financial performance are often used to identify forward-looking statements.All statements in this communication,other than those relating to historical information or current conditions,

3、are forward-looking statements.We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the Private Securities Litigation Reform Act of 1995.These forward-looking statements are subject to a number of risks and uncertainties,many of whi

4、ch are beyond control of Merck KGaA,Darmstadt,Germany,which could cause actual results to differ materially from such statements.Risks and uncertainties include,but are not limited to:the risks of more restrictive regulatory requirements regarding drug pricing,reimbursement and approval;the risk of

5、stricterregulations for the manufacture,testing and marketing of products;the risk of destabilization of political systems and the establishment of trade barriers;the risk of a changingmarketing environment for multiple sclerosis products in the European Union;the risk of greater competitive pressur

6、e due to biosimilars;the risks of research and development;therisks of discontinuing development projects and regulatory approval of developed medicines;the risk of a temporary ban on products/production facilities or of non-registration ofproducts due to non-compliance with quality standards;the ri